3E Bioventures Capital

Beijing, China
Tech Life Science focused early growth stage VC firm investing in the US China

About 3E Bioventures Capital

Investments are managed by 3E Bioventures Capital as an early and growth stage venture capital firm based in Beijing, China. Focus is placed on life science sectors including biopharma, biosciences, therapeutics, and medical devices, alongside health tech. Operations span the US and China, with portfolio companies such as MicuRx Pharmaceuticals, EpimAb Biotherapeutics, Cytek Biosciences, and Pharmacodia supported.

  • Headquarter Beijing, China
  • Sectors
    Financial Services
  • Phone
    *********
  • Website
    *********
Operational Areas
Financial Services → Private Capital & Alternative Investments
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of 3E Bioventures Capital

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by 3E Bioventures Capital

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - 3E Bioventures Capital

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

3E Bioventures Capital Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 3E Bioventures Capital

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 3E Bioventures Capital

Frequently Asked Questions about 3E Bioventures Capital

Where is 3E Bioventures Capital located?

3E Bioventures Capital is headquartered in Beijing, China.

What does 3E Bioventures Capital do?

Investments are managed by 3E Bioventures Capital as an early and growth stage venture capital firm based in Beijing, China. Focus is placed on life science sectors including biopharma, biosciences, therapeutics, and medical devices, alongside health tech. Operations span the US and China, with portfolio companies such as MicuRx Pharmaceuticals, EpimAb Biotherapeutics, Cytek Biosciences, and Pharmacodia supported.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available